The retinoblastoma protein and PML collaborate to organize heterochromatin and silence E2F-responsive genes during senescence

References

• Campisi J. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol 2001; 11:S27 - 31; PMID: 11684439
   PubMed Web of Science ®Google Scholar
• Chicas A, Wang X, Zhang C, McCurrach M, Zhao Z, Mert O, Dickins RA, Narita M, Zhang M, Lowe SW. Dissecting the unique role of the retinoblastoma tumor suppressor during cellular senescence. Cancer Cell 2010; 17:376 - 87; http://dx.doi.org/10.1016/j.ccr.2010.01.023; PMID: 20385362
   PubMed Web of Science ®Google Scholar
• Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N, Vassiliou LV, Kolettas E, Niforou K, Zoumpourlis VC, et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 2006; 444:633 - 7; http://dx.doi.org/10.1038/nature05268; PMID: 17136093
   PubMed Web of Science ®Google Scholar
• Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C, Schurra C, Garre’ M, Nuciforo PG, Bensimon A, et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 2006; 444:638 - 42; http://dx.doi.org/10.1038/nature05327; PMID: 17136094
   PubMed Web of Science ®Google Scholar
• Campisi J, Gaumont-Leclerc MF, Ferbeyre G. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005; 120:513 - 22; http://dx.doi.org/10.1016/j.cell.2005.02.003; PMID: 15734683
   PubMed Web of Science ®Google Scholar
• Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005; 120:513 - 22; http://dx.doi.org/10.1016/j.cell.2005.02.003; PMID: 15734683
   PubMed Web of Science ®Google Scholar
• Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AH, Schlegelberger B, Stein H, Dörken B, Jenuwein T, Schmitt CA. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 2005; 436:660 - 5; http://dx.doi.org/10.1038/nature03841; PMID: 16079837
   PubMed Web of Science ®Google Scholar
• Narita M, Nũnez S, Heard E, Narita M, Lin AW, Hearn SA, Spector DL, Hannon GJ, Lowe SW. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 2003; 113:703 - 16; http://dx.doi.org/10.1016/S0092-8674(03)00401-X; PMID: 12809602
   PubMed Web of Science ®Google Scholar
• Chandra T, Kirschner K, Thuret JY, Pope BD, Ryba T, Newman S, Ahmed K, Samarajiwa SA, Salama R, Carroll T, et al. Independence of repressive histone marks and chromatin compaction during senescent heterochromatic layer formation. Mol Cell 2012; 47:203 - 14; http://dx.doi.org/10.1016/j.molcel.2012.06.010; PMID: 22795131
   PubMed Web of Science ®Google Scholar
• Talluri S, Isaac CE, Ahmad M, Henley SA, Francis SM, Martens AL, Bremner R, Dick FA. A G1 checkpoint mediated by the retinoblastoma protein that is dispensable in terminal differentiation but essential for senescence. Mol Cell Biol 2010; 30:948 - 60; http://dx.doi.org/10.1128/MCB.01168-09; PMID: 20008551
   PubMed Web of Science ®Google Scholar
• Chicas A, Kapoor A, Wang X, Aksoy O, Evertts AG, Zhang MQ, Garcia BA, Bernstein E, Lowe SW. H3K4 demethylation by Jarid1a and Jarid1b contributes to retinoblastoma-mediated gene silencing during cellular senescence. Proc Natl Acad Sci U S A 2012; 109:8971 - 6; http://dx.doi.org/10.1073/pnas.1119836109; PMID: 22615382
   PubMed Web of Science ®Google Scholar
• Funayama R, Saito M, Tanobe H, Ishikawa F. Loss of linker histone H1 in cellular senescence. J Cell Biol 2006; 175:869 - 80; http://dx.doi.org/10.1083/jcb.200604005; PMID: 17158953
   PubMed Web of Science ®Google Scholar
• Zhang R, Chen W, Adams PD. Molecular dissection of formation of senescence-associated heterochromatin foci. Mol Cell Biol 2007; 27:2343 - 58; http://dx.doi.org/10.1128/MCB.02019-06; PMID: 17242207
   PubMed Web of Science ®Google Scholar
• Beauséjour CM, Krtolica A, Galimi F, Narita M, Lowe SW, Yaswen P, Campisi J. Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J 2003; 22:4212 - 22; http://dx.doi.org/10.1093/emboj/cdg417; PMID: 12912919
   PubMed Web of Science ®Google Scholar
• Dimova DK, Dyson NJ. The E2F transcriptional network: old acquaintances with new faces. Oncogene 2005; 24:2810 - 26; http://dx.doi.org/10.1038/sj.onc.1208612; PMID: 15838517
   PubMed Web of Science ®Google Scholar
• Dannenberg J-H, van Rossum A, Schuijff L, te Riele H. Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions. Genes Dev 2000; 14:3051 - 64; http://dx.doi.org/10.1101/gad.847700; PMID: 11114893
   PubMed Web of Science ®Google Scholar
• Sage J, Mulligan GJ, Attardi LD, Miller A, Chen S, Williams B, Theodorou E, Jacks T. Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. Genes Dev 2000; 14:3037 - 50; http://dx.doi.org/10.1101/gad.843200; PMID: 11114892
   PubMed Web of Science ®Google Scholar
• Sage J, Miller AL, Pérez-Mancera PA, Wysocki JM, Jacks T. Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature 2003; 424:223 - 8; http://dx.doi.org/10.1038/nature01764; PMID: 12853964
   PubMed Web of Science ®Google Scholar
• Ferbeyre G, de Stanchina E, Querido E, Baptiste N, Prives C, Lowe SW. PML is induced by oncogenic ras and promotes premature senescence. Genes Dev 2000; 14:2015 - 27; PMID: 10950866
   PubMed Web of Science ®Google Scholar
• Pearson M, Carbone R, Sebastiani C, Cioce M, Fagioli M, Saito S, Higashimoto Y, Appella E, Minucci S, Pandolfi PP, et al. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 2000; 406:207 - 10; http://dx.doi.org/10.1038/35021000; PMID: 10910364
   PubMed Web of Science ®Google Scholar
• Bischof O, Kirsh O, Pearson M, Itahana K, Pelicci PG, Dejean A. Deconstructing PML-induced premature senescence. EMBO J 2002; 21:3358 - 69; http://dx.doi.org/10.1093/emboj/cdf341; PMID: 12093737
   PubMed Web of Science ®Google Scholar
• Jensen K, Shiels C, Freemont PS. PML protein isoforms and the RBCC/TRIM motif. Oncogene 2001; 20:7223 - 33; http://dx.doi.org/10.1038/sj.onc.1204765; PMID: 11704850
   PubMed Web of Science ®Google Scholar
• Vernier M, Bourdeau V, Gaumont-Leclerc MF, Moiseeva O, Bégin V, Saad F, Mes-Masson AM, Ferbeyre G. Regulation of E2Fs and senescence by PML nuclear bodies. Genes Dev 2011; 25:41 - 50; http://dx.doi.org/10.1101/gad.1975111; PMID: 21205865
   PubMed Web of Science ®Google Scholar
• de Stanchina E, Querido E, Narita M, Davuluri RV, Pandolfi PP, Ferbeyre G, Lowe SW. PML is a direct p53 target that modulates p53 effector functions. Mol Cell 2004; 13:523 - 35; http://dx.doi.org/10.1016/S1097-2765(04)00062-0; PMID: 14992722
   PubMed Web of Science ®Google Scholar
• Zhang R, Poustovoitov MV, Ye X, Santos HA, Chen W, Daganzo SM, Erzberger JP, Serebriiskii IG, Canutescu AA, Dunbrack RL, et al. Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. Dev Cell 2005; 8:19 - 30; http://dx.doi.org/10.1016/j.devcel.2004.10.019; PMID: 15621527
   PubMed Web of Science ®Google Scholar
• Ye X, Zerlanko B, Zhang R, Somaiah N, Lipinski M, Salomoni P, Adams PD. Definition of pRB- and p53-dependent and -independent steps in HIRA/ASF1a-mediated formation of senescence-associated heterochromatin foci. Mol Cell Biol 2007; 27:2452 - 65; http://dx.doi.org/10.1128/MCB.01592-06; PMID: 17242198
   PubMed Web of Science ®Google Scholar
• Narita M, Narita M, Krizhanovsky V, Nuñez S, Chicas A, Hearn SA, Myers MP, Lowe SW. A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation. Cell 2006; 126:503 - 14; http://dx.doi.org/10.1016/j.cell.2006.05.052; PMID: 16901784
   PubMed Web of Science ®Google Scholar
• Alcalay M, Tomassoni L, Colombo E, Stoldt S, Grignani F, Fagioli M, Szekely L, Helin K, Pelicci PG. The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein. Mol Cell Biol 1998; 18:1084 - 93; PMID: 9448006
   PubMed Web of Science ®Google Scholar
• Isaac CE, Francis SM, Martens AL, Julian LM, Seifried LA, Erdmann N, Binné UK, Harrington L, Sicinski P, Bérubé NG, et al. The retinoblastoma protein regulates pericentric heterochromatin. Mol Cell Biol 2006; 26:3659 - 71; http://dx.doi.org/10.1128/MCB.26.9.3659-3671.2006; PMID: 16612004
   PubMed Web of Science ®Google Scholar
• Andrusiak MG, Vandenbosch R, Dick FA, Park DS, Slack RS. LXCXE-independent chromatin remodeling by Rb/E2f mediates neuronal quiescence. Cell Cycle 2013; 12:1416 - 23; http://dx.doi.org/10.4161/cc.24527; PMID: 23574720
   PubMed Web of Science ®Google Scholar
• Le XF, Vallian S, Mu ZM, Hung MC, Chang KS. Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis. Oncogene 1998; 16:1839 - 49; http://dx.doi.org/10.1038/sj.onc.1201705; PMID: 9583681
   PubMed Web of Science ®Google Scholar
• Fagioli M, Alcalay M, Tomassoni L, Ferrucci PF, Mencarelli A, Riganelli D, Grignani F, Pozzan T, Nicoletti I, Grignani F, et al. Cooperation between the RING + B1-B2 and coiled-coil domains of PML is necessary for its effects on cell survival. Oncogene 1998; 16:2905 - 13; http://dx.doi.org/10.1038/sj.onc.1201811; PMID: 9671411
   PubMed Web of Science ®Google Scholar
• Liu JH, Mu ZM, Chang KS. PML suppresses oncogenic transformation of NIH/3T3 cells by activated neu. J Exp Med 1995; 181:1965 - 73; http://dx.doi.org/10.1084/jem.181.6.1965; PMID: 7759992
   PubMed Web of Science ®Google Scholar
• Mu ZM, Chin KV, Liu JH, Lozano G, Chang KS. PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol Cell Biol 1994; 14:6858 - 67; PMID: 7935403
   PubMed Web of Science ®Google Scholar
• Salomoni P, Pandolfi PP. The role of PML in tumor suppression. Cell 2002; 108:165 - 70; http://dx.doi.org/10.1016/S0092-8674(02)00626-8; PMID: 11832207
   PubMed Web of Science ®Google Scholar
• Wang ZG, Delva L, Gaboli M, Rivi R, Giorgio M, Cordon-Cardo C, Grosveld F, Pandolfi PP. Role of PML in cell growth and the retinoic acid pathway. Science 1998; 279:1547 - 51; http://dx.doi.org/10.1126/science.279.5356.1547; PMID: 9488655
   PubMed Web of Science ®Google Scholar
• Dick FA. Structure-function analysis of the retinoblastoma tumor suppressor protein - is the whole a sum of its parts?. Cell Div 2007; 2:26; http://dx.doi.org/10.1186/1747-1028-2-26; PMID: 17854503
   PubMed Web of Science ®Google Scholar
• Carbone R, Botrugno OA, Ronzoni S, Insinga A, Di Croce L, Pelicci PG, Minucci S. Recruitment of the histone methyltransferase SUV39H1 and its role in the oncogenic properties of the leukemia-associated PML-retinoic acid receptor fusion protein. Mol Cell Biol 2006; 26:1288 - 96; http://dx.doi.org/10.1128/MCB.26.4.1288-1296.2006; PMID: 16449642
   PubMed Web of Science ®Google Scholar
• Nielsen SJ, Schneider R, Bauer UM, Bannister AJ, Morrison A, O’Carroll D, Firestein R, Cleary M, Jenuwein T, Herrera RE, et al. Rb targets histone H3 methylation and HP1 to promoters. Nature 2001; 412:561 - 5; http://dx.doi.org/10.1038/35087620; PMID: 11484059
   PubMed Web of Science ®Google Scholar
• Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997; 88:593 - 602; http://dx.doi.org/10.1016/S0092-8674(00)81902-9; PMID: 9054499
   PubMed Web of Science ®Google Scholar
• Guccione E, Lethbridge KJ, Killick N, Leppard KN, Banks L. HPV E6 proteins interact with specific PML isoforms and allow distinctions to be made between different POD structures. Oncogene 2004; 23:4662 - 72; http://dx.doi.org/10.1038/sj.onc.1207631; PMID: 15107834
   PubMed Web of Science ®Google Scholar
• Cecchini MJ, Dick FA. The biochemical basis of CDK phosphorylation-independent regulation of E2F1 by the retinoblastoma protein. Biochem J 2011; 434:297 - 308; http://dx.doi.org/10.1042/BJ20101210; PMID: 21143199
   PubMed Web of Science ®Google Scholar
• Cortázar D, Kunz C, Selfridge J, Lettieri T, Saito Y, MacDougall E, Wirz A, Schuermann D, Jacobs AL, Siegrist F, et al. Embryonic lethal phenotype reveals a function of TDG in maintaining epigenetic stability. Nature 2011; 470:419 - 23; http://dx.doi.org/10.1038/nature09672; PMID: 21278727
   PubMed Web of Science ®Google Scholar
• Coschi CH, Martens AL, Ritchie K, Francis SM, Chakrabarti S, Berube NG, Dick FA. Mitotic chromosome condensation mediated by the retinoblastoma protein is tumor-suppressive. Genes Dev 2010; 24:1351 - 63; http://dx.doi.org/10.1101/gad.1917610; PMID: 20551166
   PubMed Web of Science ®Google Scholar